This is Session 4 in the BioBusiness Insights: Opportunities in Regenerative Medicine series. Find out more about the full series.
In this session, Paul Brennan, Managing Director of PolyNovo, will share how PolyNovo enters various global markets, how they partner with key opinion leaders in the development of new products and what underlying drivers are used to assess product development priorities.
With a Polymer that can be developed into many different medical devices, how does PolyNovo select from the embarrassment of choice?
Session 4 Details
Date: Tuesday 8 September 2020 Time: 9:00 am – 10:00 am AEST Format: This event will be delivered on a virtual platform – you will receive a link to join via a confirmation email following registration. Registration:
Single session: Members $35; Non-members $45
Unsure if your organisation is a member? Check our member directory.
Mr Brennan has extensive knowledge, exposure and understanding of the health system through his clinical background and commercial exposure with various multinational companies. He has coordinated the marketing, global strategy development, new product development and regulatory processes for the Asia-Pacific region for industry-leading organisations in relation to medical products and devices. Mr Brennan has an intimate knowledge of the manufacturing and production processes.
Previously he was Marketing Director Australia and New Zealand and Sales Director New Zealand for Smith & Nephew Healthcare from 2008 to his commencement with PolyNovo in February 2015. Mr Brennan holds a MBA from Swinburne University, a Bachelor of Science (Nursing) from the University of New England in NSW, Certificate in Midwifery Central Coast Area Health Service NSW, and General Nursing certificate from St Vincent’s Hospital Darlinghurst NSW.
Christelle Damiens, Managing Director, Exportia
Christelle Damiens founded Exportia in 2006, shortly after Christelle migrated from France to Australia. She started her career at IBM Paris looking after large corporate customers, but she decided to turn her back to a corporate career to go back to her passion for international business and to focus particularly on small businesses.
Based on her 20 years of sales experience internationally in a high tech environment, she found that small and medium sized businesses always face the same challenges. They often lack the time, financial and human resources to take the step. Following years working closely with more than hundred innovative small to medium sized companies, she now has a track record of taking businesses to their first million Euros in sales and beyond. On this journey, she has developed a 4-Step-framework and a set of tools tailored to the needs of technology companies that enable them to successfully scale in the European market.
She is a speaker and an Amazon best seller author
Silvio Tiziani, CEO, CCRM Australia
Silvio Tiziani has played a key role in the establishment of Centre for Commercialisation of Regenerative Medicine (CCRM) Australia with the support of Canada’s CCRM, the Victorian Government and MTPConnect. Silvio is also Director, External Strategy and Planning at the Australian Regenerative Medicine Institute (ARMI). Silvio’s extensive knowledge of the research landscape is well utilised with his networks within the industry, international organisations and state and federal governments.
Silvio has extensive experience in private and public organisations, with a focus on laboratory-based services in government, private organisations, healthcare and research/academia.
In addition to qualifications that include a Bachelor of Science from Swinburne University and a Masters of Business Administration from Monash University, Silvio is also a graduate of the Australian Institute of Company Directors (GAICD). Silvio has extensive experience in financial analysis and budget management, business development, strategic planning and corporate governance along with strong interpersonal skills to lead staff.
Silvio also chairs the Ausbiotech Regenerative Medicine Advisory Group. Comprising leading representatives from industry and academia within the Australian regenerative medicine the Group provides specialist advice to Ausbiotech, Australia’s member-based biotechnology organisation, a peak body that promotes the global growth of Australian biotechnology.